ALS News Today2d
New ALS trial data show nearly 2-year survival benefit with NP001
A 22-month survival benefit was seen for a subset of ALS patients whose disease did not progress when treated with NP001 in ...
Medical News Today2d
FDA-approved nasal spray for severe depression can lead to remission
The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of major depression in ...
WOOD Grand Rapids on MSN3d
Nose spray to treat depression? FDA approves first-of-its-kind medicine
The U.S. Food and Drug Administration has approved a nose spray to help treat depression, Johnson & Johnson announced Tuesday ...